Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moulis

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Vnitrni Lekarstvi|July 15, 2011
[Successful treatment of Erdheim-Chester disease by 2-chlorodeoxyadenosine-based chemotherapy. Two case studies and a literature review]Z Adam, R Koukalová, A Sprláková, et al.
Vnitrni Lekarstvi|May 22, 2013
[Invasive aspergillosis in hematooncological patients: advantages and disadvantages of various diagnostic methods, treatment options and financial costs of therapy]Z Rácil, J Mayer, I Kocmanová, et al.
Neoplasma|July 13, 2011
Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patientsJ Halamkova, I Kiss, Z Pavlovsky, et al.
Vnitrni Lekarstvi|April 17, 2010
[Treatment of AL-amyloidosis--results from one clinic and review of published experience with new agents (bortezomib, thalidomide and lenalidomide) in AL-amyloidosis]Z Adam, L Pour, M Krejcí, et al.
Vnitrni Lekarstvi|April 11, 2012
[The role of PET-CT in decision making on the treatment of localized nodular form of pulmonary AL-amyloidosis]Z Adam, M Elleder, M Moulis, et al.
Neoplasma|December 25, 2012
Clinical impact of PAI 1 4G/5G gene polymorphism in colorectal carcinoma patientsJ Halamkova, I Kiss, Z Pavlovsky, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|November 11, 2011
[Partial regression of CNS lesions of Erdheim-Chester disease after treatment with 2-chlorodeoxadenosine and their full remission following treatment with lenalidomide]Z Adam, A Sprláková, Z Rehák, et al.
Vnitrni Lekarstvi|January 15, 2010
[Diabetes insipidus followed, after 4 years, with dysarthria and mild right-sided hemiparesis--the first clinical signs of Erdheim-Chester disease. Description and depiction of a case with a review of information on the disease]Z Adam, K Balsíková, L Pour, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|February 22, 2012
[Six-year follow-up of a patient with multiple angiomatosis involving skeleton, thoracic and abdominal cavities and the gut wall]Z Adam, M Matýšková, M Tomíška, et al.
Gynecologie, Obstetrique & Fertilite|March 14, 2007
[Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population]P Rozenberg, L Bussières, S Chevret, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Vnitrni Lekarstvi|July 15, 2011
[Successful treatment of Erdheim-Chester disease by 2-chlorodeoxyadenosine-based chemotherapy. Two case studies and a literature review]Z Adam, R Koukalová, A Sprláková, et al.
Vnitrni Lekarstvi|May 22, 2013
[Invasive aspergillosis in hematooncological patients: advantages and disadvantages of various diagnostic methods, treatment options and financial costs of therapy]Z Rácil, J Mayer, I Kocmanová, et al.
Neoplasma|July 13, 2011
Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patientsJ Halamkova, I Kiss, Z Pavlovsky, et al.
Vnitrni Lekarstvi|April 17, 2010
[Treatment of AL-amyloidosis--results from one clinic and review of published experience with new agents (bortezomib, thalidomide and lenalidomide) in AL-amyloidosis]Z Adam, L Pour, M Krejcí, et al.
Vnitrni Lekarstvi|April 11, 2012
[The role of PET-CT in decision making on the treatment of localized nodular form of pulmonary AL-amyloidosis]Z Adam, M Elleder, M Moulis, et al.
Neoplasma|December 25, 2012
Clinical impact of PAI 1 4G/5G gene polymorphism in colorectal carcinoma patientsJ Halamkova, I Kiss, Z Pavlovsky, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|November 11, 2011
[Partial regression of CNS lesions of Erdheim-Chester disease after treatment with 2-chlorodeoxadenosine and their full remission following treatment with lenalidomide]Z Adam, A Sprláková, Z Rehák, et al.
Vnitrni Lekarstvi|January 15, 2010
[Diabetes insipidus followed, after 4 years, with dysarthria and mild right-sided hemiparesis--the first clinical signs of Erdheim-Chester disease. Description and depiction of a case with a review of information on the disease]Z Adam, K Balsíková, L Pour, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|February 22, 2012
[Six-year follow-up of a patient with multiple angiomatosis involving skeleton, thoracic and abdominal cavities and the gut wall]Z Adam, M Matýšková, M Tomíška, et al.
Gynecologie, Obstetrique & Fertilite|March 14, 2007
[Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population]P Rozenberg, L Bussières, S Chevret, et al.
Pageof 7